Immupharma Share Discussion Threads

[john09] 25/1/2018 12:17

8 pence spread too

[john09] 25/1/2018 12:17

I think someone wants your shares

[john09] 25/1/2018 12:16

Out of auction at £1.43

[ashehzi] 25/1/2018 12:15

big orders in place?

[rossy73] 25/1/2018 12:15

On the various tranches in IMM I've made just over 3 times my original investment. There were just too many red flags for me and I opted to protect my capital instead.

[flavio_monteiro] 25/1/2018 12:15

Just mugged all with stop losses...watch it recover.

[davr0s] 25/1/2018 12:14

It's in auction and I've been stopped. Think I'll wait to see if new has leaked.

[ashehzi] 25/1/2018 12:14

its in auction, just this stock, anyone?

[john09] 25/1/2018 12:13

I think it’s in auction at £132.5

[john09] 25/1/2018 12:12

Huge tree shake or news has leaked

[hamila01] 25/1/2018 12:11

And through all of this IMM still have the £10m.Does anyone know when any significant holdings need to be declared in relation to the 7m new shares coming in at the end of January?

[john09] 25/1/2018 12:10

£1.25

[john09] 25/1/2018 12:09

What happened

[hamila01] 25/1/2018 12:08

Be interesting to see how many big transactions go through today....

[pat134] 25/1/2018 12:02

invests since November 2017. Earnings almost gone and within a few days. I lose confidence in Immupharma. Somehow dubious what is going on .. sorry for my English. I come from Switzerland

[cockerspaniel] 25/1/2018 12:01

To those people who are questioning Tim McCarthy - he is the non-exec Chairman.
He does not run Immupharma - the people who make the decisons are Dimitri and Robert Zimmer.

[w1ndjammer] 25/1/2018 11:57

OOOoops double post

[dontshoutatonce] 25/1/2018 11:31

Quite so Flavio. Fact is, IMM have the money, whomever sold it to them, and IMM have all the bargaining chips now. I hope Tim is up to the job of getting the very best for patients and shareholders alike asa...

[jpleight] 25/1/2018 11:28

for Lupuzor, do we have hard data IN HUMANS for indications other than Lupus? People keep saying 'extra indications' and I havent seen any data not derived from lupus trials

[top tips] 25/1/2018 11:27

They raised money to buy into extra P140 indications, to pay for the open label Lupuzor study and to have a better negotiating position for a deal or takeover (financially and in terms of the expanded P140 pipeline). All that is positive.